Some features of beckman.com will be unavailable from 8:00 p.m. PDT Saturday, December 7 until 12:00 a.m. PDT, Sunday, December 8 for planned maintenance. During this time, you will not be able to log in to use account features such as online shopping, shopping lists and order tracking.
Please ensure your orders are processed prior to this maintenance period or contact Client Services for additional assistance.
Cellular immunotherapy modifies a person's immune cells (e.g., through genetic engineering or modulating protein expression profile) before reintroducing them back into the body for therapeutic purposes. For example, T-cells can be isolated directly from a patient and then modified in a research laboratory to express receptors targeting cancer cell-specific antigens. These modified T-cells are then allowed to multiply in incubators, after which they are reintroduced in large numbers back into the patient to seek out cancer cells for immune-mediated elimination.2
1. Z. Tao, et al., "Cellular immunotherapy of cancer: an overview and future directions," Immunotherapy 9(7):589-606, 2017.
Oops. The page you wanted could not be found, so we brought you to something similar. If you still can't find what you want, try searching our site instead.